Want to join the conversation?
$CTXS 2Q15 Call: Total revenue was $797MM, adjusted operating margin was up to 24.8%, adjusted EPS was $1 per share up 20.9% and we generated cash flow from ops of $201MM. In the quarter we continued to see some affects impact largely on EMEA, but in line with our expectations. From a geo perspective excluding SaaS total revenue in EMEA was flat.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.